Status:
RECRUITING
Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer
Lead Sponsor:
Herlev Hospital
Conditions:
Anal Cancer
Anal Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
A single-arm, prospective, Phase II, single-center clinical trial that will investigate if daily online adaptive radiotherapy for anal cancer will significantly reduce early treatment-related GI toxic...
Eligibility Criteria
Inclusion
- Biopsy-verified anal cancer
- Eligible for curative intended radiotherapy
- Written and oral consent
Exclusion
- Other malignant disease within the past 5 years (excluding basal cell carcinoma)
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2031
Estimated Enrollment :
205 Patients enrolled
Trial Details
Trial ID
NCT05438836
Start Date
January 1 2022
End Date
January 1 2031
Last Update
September 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oncology dept, Herlev and Gentofte Hospital
Herlev, Denmark, 2730